Clinical Trial Consultants AB (CTC) is a full-service CRO with focus on Phase I and Phase II clinical trials. Our internal Site Network, comprising five state-of-the art clinical research units in Uppsala, Stockholm and Linköping, supports the conduct of Phase I to Phase IV clinical trials as well as medical device investigations.  
CTC was founded in 2011 and has, since then, participated in over 400 industry sponsored clinical trials on behalf of small start-ups as well as large international pharmaceutical companies and CROs. Our track record includes, but is not limited to, first-in-human (FIH), PET/MR, early precision QT (EPQT), drug-drug and food interaction, pharmaco-EEG, biosimilar, bioequivalence, and bioavailability studies, new drug delivery systems, medical device investigations and Phase II studies. We also participate in international, multicentre Phase III-IV studies in patients with various diagnoses.  
Our Site Network work in close collaboration with the Clinical Operations, Biometrics, Pharmacovigilance and DMPK & Clinical Pharmacology units to provide a true full-service option to our customers.  Since 2015, CTC is owned by Center for Translational Research Sweden AB (CTR). Currently, CTR comprises five subsidiaries besides CTC: RegSmart Life Science AB, Lablytica Life Science AB, Toxicology Knowledge Team Sweden AB (TKT), RegFile AB and MetaSafe AB. Together, the six sister companies form a solid basis for translational research. 
More than 100 co-workers constitute the backbone of our company. In addition, we have access to a large pool of hourly based clinical research nurses and clinical research physicians with long experience of clinical trials. Closely connected to CTC are also a number of experts in various therapeutic areas. 
We believe that our workplace should not only be full of expertise but also of warmth, transparency and flexibility. A place that is open for fast adaptation to new, innovative techniques. Committed to our work, we aim for high-quality deliverables that will meet our clients’ expectations. We focus on personalised service with a collaborative and proactive approach. With all main functions under the same roof, we can commit to efficient information exchange, minimum response time and swift issue resolution. It is also important for us to create trust in relation to the healthy volunteers and patients who participate in our studies. All to facilitate the translation of science into treatment